Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol

被引:72
作者
Griesinger, Georg [1 ]
Verweij, Pierre J. M. [2 ]
Gates, Davis [3 ]
Devroey, Paul [4 ]
Gordon, Keith [3 ]
Stegmann, Barbara J. [3 ]
Tarlatzis, Basil C. [5 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Reprod Med & Gynecol Endocrinol, Campus Luebeck, Lubeck, Germany
[2] MSD BV, Oss, Netherlands
[3] Merck & Co Inc, Kenilworth, NJ USA
[4] Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium
[5] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Obstet & Gynecol 1, Sch Med, GR-54006 Thessaloniki, Greece
关键词
IN-VITRO FERTILIZATION; POLYCYSTIC OVARIES; OOCYTE MATURATION; WOMEN; STIMULATION; IVF; PREVENTION; OHSS; GONADOTROPINS; AGONIST;
D O I
10.1371/journal.pone.0149615
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Study Question What is the threshold for the prediction of moderate to severe or severe ovarian hyperstimulation syndrome (OHSS) based on the number of growing follicles >= 11 mm and/or estradiol (E-2) levels? Summary Answer The optimal threshold of follicles >= 11 mm on the day of hCG to identify those at risk was 19 for both moderate to severe OHSS and for severe OHSS. Estradiol (E-2) levels were less prognostic of OHSS than the number of follicles >= 11 mm. What Is Known Already In comparison to long gonadotropin-releasing hormone (GnRH) agonist protocols, the risk of severe OHSS is reduced by approximately 50% in a GnRH antagonist protocol for ovarian stimulation prior to in vitro fertilisation (IVF), while the two protocols provide equal chances of pregnancy per initiated cycle. Nevertheless, moderate to severe OHSS may still occur in GnRH antagonist protocols if human chorionic gonadotropin (hCG) is administered to trigger final oocyte maturation, especially in high responder patients. Severe OHSS following hCG trigger may occur with an incidence of 1-2% in a relatively young (aged 18 to 36 years) IVF population treated in a GnRH-antagonist protocol. Study Design, Size, Duration From the Engage, Ensure and Trust trials, in total, 2,433 women who received hCG for oocyte maturation and for whom the number of follicles >= 11 mm and the level of E-2 on the day of hCG administration were known were included in the analyses. Participants/Materials, Setting, Methods The threshold for OHSS prediction of moderate and severe OHSS was assessed in women treated with corifollitropin alfa or daily recombinant follicle stimulation hormone (rFSH) in a gonadotropin-releasing hormone (GnRH)-antagonist protocol. Receiver operating characteristics curve analyses for moderate to severe OHSS and severe OHSS were performed on the combined dataset and the sensitivity and specificity for the optimal threshold of number of follicles >= 11 mm, E-2 levels on the day of (hCG), and a combination of both, were determined. Main Results and the Role of Chance The optimal threshold of follicles >= 11 mm on the day of hCG to identify those at risk of moderate to severe OHSS was 19 (sensitivity and specificity 62.3% and 75.6%, respectively) and for severe OHSS was also 19 (sensitivity and specificity 74.3% and 75.3%, respectively). The positive and negative predictive values were 6.9% and 98.6%, respectively, for moderate to severe OHSS, and 4.2% and 99.5% for severe OHSS. Limitations, Reasons for Caution This was a retrospective analysis of combined data from three trials following ovarian stimulation with two different gonadotropins. Wider Implications of the Findings For patients with 19 follicles or more >= 11 mm on the day of hCG, measures to prevent the development of OHSS should be considered. Secondary preventive measures include cycle cancellation or coasting, use of a GnRH agonist to trigger final oocyte maturation in place of hCG and a freeze all strategy.
引用
收藏
页数:14
相关论文
共 28 条
[1]  
Agents stimulating gonadal function in the human, WHO TECH REP SER, V514, P1
[2]  
Alper Michael M, 2009, J Exp Clin Assist Reprod, V6, P3
[3]   A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries [J].
Child, TJ ;
Phillips, SJ ;
Abdul-Jalil, AK ;
Gulekli, B ;
Tan, SL .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (04) :665-670
[4]   Understanding ovarian hyperstimulation syndrome [J].
Delbaere, A ;
Smits, G ;
De Leener, A ;
Costagliola, S ;
Vassart, G .
ENDOCRINE, 2005, 26 (03) :285-289
[5]   Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577
[6]   A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol [J].
Devroey, P. ;
Boostanfar, R. ;
Koper, N. P. ;
Mannaerts, B. M. J. L. ;
IJzerman-Boon, P. C. ;
Fauser, B. C. J. M. .
HUMAN REPRODUCTION, 2009, 24 (12) :3063-3072
[7]   An OHSS-Free Clinic by segmentation of IVF treatment [J].
Devroey, Paul ;
Polyzos, Nikolaos P. ;
Blockeel, Christophe .
HUMAN REPRODUCTION, 2011, 26 (10) :2593-2597
[8]   Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study [J].
Fadini, R. ;
Dal Canto, M. B. ;
Renzini, M. Mignini ;
Brambillasca, F. ;
Comi, R. ;
Fumagalli, D. ;
Lain, M. ;
Merola, M. ;
Milani, R. ;
De Ponti, E. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (03) :343-351
[9]   In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles [J].
Gremeau, Anne-Sophie ;
Andreadis, Natasha ;
Fatum, Muhammad ;
Craig, Jo ;
Turner, Karen ;
Mcveigh, Enda ;
Child, Tim .
FERTILITY AND STERILITY, 2012, 98 (02) :355-360
[10]   Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study [J].
Griesinger, G. ;
von Otte, S. ;
Schroer, A. ;
Ludwig, A. K. ;
Diedrich, K. ;
Al-Hasani, S. ;
Schultze-Mosgau, A. .
HUMAN REPRODUCTION, 2007, 22 (05) :1348-1352